BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31981081)

  • 21. Ichthyosiform Pityriasis Rubra Pilaris-Like Eruption Secondary to Ponatinib Therapy: Case Report and Literature Review.
    Eber AE; Rosen A; Oberlin KE; Giubellino A; Romanelli P
    Drug Saf Case Rep; 2017 Nov; 4(1):19. PubMed ID: 29138996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pityriasis rubra pilaris].
    Quenan S; Laffitte E
    Ann Dermatol Venereol; 2018 Jan; 145(1):50-59. PubMed ID: 29290415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin.
    Mota F; Carvalho S; Sanches M; Selores M
    Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):15-7. PubMed ID: 27014774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bevacizumab-induced pityriasis rubra pilaris-like eruption.
    Brown S; Fletcher JW; Fiala KH
    Proc (Bayl Univ Med Cent); 2016 Jul; 29(3):335-6. PubMed ID: 27365893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient.
    Gómez M; Ruelas ME; Welsh O; Arcaute HD; Ocampo-Candiani J
    J Drugs Dermatol; 2007 Mar; 6(3):337-9. PubMed ID: 17373198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pityriasis rubra pilaris, type IV.
    Bragg J; Witkiewicz A; Orlow SJ; Schaffer JV
    Dermatol Online J; 2005 Dec; 11(4):14. PubMed ID: 16403386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pityriasis rubra pilaris: an unusual cutaneous complication of AIDS.
    Bonomo RA; Korman N; Nagashima-Whalen L; Briggs J; Graham R; Salata RA
    Am J Med Sci; 1997 Aug; 314(2):118-21. PubMed ID: 9258214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of pityriasis rubra pilaris with adalimumab - case report.
    Bravo EA; Carrion L; Paucar SM; Mendoza R; Rivera C
    Dermatol Online J; 2014 Apr; 20(4):22374. PubMed ID: 24746310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent Pityriasis Rubra Pilaris: A Case Report.
    MacGillivray ME; Fiorillo L
    J Cutan Med Surg; 2018; 22(6):624-626. PubMed ID: 29754526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sofosbuvir-Induced Erythrodermic Pityriasis Rubra Pilaris-Like Drug Eruption.
    Cheung EJ; Jedrych JJ; English JC
    J Drugs Dermatol; 2015 Oct; 14(10):1161-2. PubMed ID: 26461830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab.
    Hanfstingl K; Pekar-Lukacs A; Motz R; Guenova E; Hoetzenecker W
    Case Rep Dermatol; 2018; 10(2):97-100. PubMed ID: 29867429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adalimumab for the treatment of pityriasis rubra pilaris: a case report.
    Wassef C; Lombardi A; Rao BK
    Cutis; 2012 Nov; 90(5):244-7. PubMed ID: 23270195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dermatomyositis with a pityriasis rubra pilaris-like eruption: a little-known distinctive cutaneous manifestation of dermatomyositis.
    Requena L; Grilli R; Soriano L; Escalonilla P; Fariña C; Martín L
    Br J Dermatol; 1997 May; 136(5):768-71. PubMed ID: 9205515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pityriasis rubra pilaris with focal acantholytic dyskeratosis during treatment with imiquimod 5% cream].
    Gómez-Moyano E; Crespo-Erchiga A; Vera Casaño A; Sanz Trelles A
    Actas Dermosifiliogr; 2010 Dec; 101(10):898-900. PubMed ID: 21159271
    [No Abstract]   [Full Text] [Related]  

  • 35. Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of Wong's dermatomyositis.
    Caporali R; Cavagna L; Bellosta M; Bogliolo L; Montecucco C
    Clin Rheumatol; 2004 Feb; 23(1):63-5. PubMed ID: 14749988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris.
    Shao S; Chen J; Swindell WR; Tsoi LC; Xing X; Ma F; Uppala R; Sarkar MK; Plazyo O; Billi AC; Wasikowski R; Smith KM; Honore P; Scott VE; Maverakis E; Kahlenberg JM; Wang G; Ward NL; Harms PW; Gudjonsson JE
    JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34491907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical pityriasis rubra pilaris associated with arthropathy and osteoporosis: a case report with 15-year follow-up.
    Behr FD; Bangert JL; Hansen RC
    Pediatr Dermatol; 2002; 19(1):46-51. PubMed ID: 11860571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial pityriasis rubra pilaris.
    Vanderhooft SL; Francis JS; Holbrook KA; Dale BA; Fleckman P
    Arch Dermatol; 1995 Apr; 131(4):448-53. PubMed ID: 7726588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secukinumab monotherapy successfully treated severe refractory type V (atypical juvenile) pityriasis rubra pilaris: A case report and literature review.
    Liang JY; Ye RX; Tian X; Zhang SQ; Zhang XB
    Dermatol Ther; 2020 Nov; 33(6):e14097. PubMed ID: 32725719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pityriasis rubra pilaris and celiac sprue with malabsorption.
    Randle HW; Winkelmann RK
    Cutis; 1980 Jun; 25(6):626-7. PubMed ID: 7379593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.